Cysteamine Compared to Hydroquinone in Melasma

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 28, 2019

Primary Completion Date

September 11, 2020

Study Completion Date

November 11, 2020

Conditions
Melasma
Interventions
COMBINATION_PRODUCT

5% cysteamine cream

5% cysteamine cream (Cyspera®) was acquired from Scientis APAC Pte. Ltd. (Singapore, Singapore).Subjects were instructed to thinly apply the designated creams to their whole face every evening 15 minutes after cleansing their faces with a designated soap and the application of a skin moisturizer. The cysteamine cream was washed off 15 minutes after application

COMBINATION_PRODUCT

hydroquinone cream group

4% w/w hydroquinone cream (Melquine™) and 0.06% w/w betamethasone valerate cream (Rinderon®-V; equivalent to 0.05% betamethasone) were acquired from Sinphar Pharmaceutical Co., Ltd. (Yilan, Taiwan). Subjects were instructed to thinly apply the designated creams to their whole face every evening 15 minutes after cleansing their faces with a designated soap and the application of a skin moisturizer. Subjects in the hydroquinone cream group were told to apply a 2:1 ratio of the hydroquinone and betamethasone creams. The hydroquinone/betamethasone creams were left on the skin until the following morning.

Trial Locations (1)

404332

China Medical University Hospital, Taichung

All Listed Sponsors
lead

China Medical University Hospital

OTHER

NCT05969587 - Cysteamine Compared to Hydroquinone in Melasma | Biotech Hunter | Biotech Hunter